The Lancet. Oncology
Adjuvant capecitabine in early-stage triple-negative breast cancer? Yes, but for whom?
William M Sikov
Published: 202510.1016/S1470-2045(25)00621-7
No abstract available for this study.
William M Sikov
No abstract available for this study.